Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Pfizer’s diabetes drug, danuglipron, demonstrates comparable weight loss to Novo Nordisk’s Ozempic in a recent mid-stage trial. Explore how this breakthrough could shape the future of type 2 diabetes treatment and weight loss market.
Endocrinology, Diabetes, Metabolism June 14th 2023
Unveiling the Cognitive Potential of Multivitamin Supplementation in Older Adults A recent study has unearthed new insights into the effects of multivitamin supplementation on memory performance in older adults, bringing implications for medical professionals and their approach towards cognitive health in their aging patients. Key Points: Additional Points: “We can only speculate at this time. Older adults with cardiovascular risk factors tend to have lower vitamin and mineral circulating levels. Supplementation with multivitamins may help restore these deficiencies, providing [a] secondary benefit to cognitive health.” Adam M. Brickman, PhD, Professor of Neuropsychology at Columbia University Vagelos College of Physicians and Surgeons.
Geriatrics June 13th 2023
Journal of Clinical Pathways
Leveraging Clinical Decision Support Tools for Optimized Cancer Care Delivery For oncologists, navigating the complicated world of cancer treatment can be a challenging undertaking. Clinical decision support tools like Flatiron Assist may be able to help as they offer better instructions and make it possible to administer high-quality care. Key Points: “Given the increasing complexity of the oncology treatment landscape, this study found that utilizing a customizable CDS tool like FA provides an opportunity for custom preferred pathways to optimize cancer treatment ordering in cases where NCCN guidelines are less clear and that regardless of the pathway in place, providers order preferred treatment options a large majority of the time.” Study Conclusion
Oncology, Medical June 12th 2023
Psychiatrist.com
Study Reveals Different Effects of Antipsychotics on Weight Gain: Key Findings for Physicians A new study analyzed the impact of different antipsychotic medications on weight gain, emphasizing the importance of considering dose and specific drugs for individual patients. The study provides valuable insights for physicians to make informed decisions regarding antipsychotic use. Key Points: “Weight gain from medication is one of the most problematic adverse effects facing patients with serious mental illness… It can be a real barrier in getting people to take their meds.” Michel Sabé, MD, corresponding author
Internal Medicine June 8th 2023
Annals of Internal Medicine
Similarities in Quality and Cost of Care: Allopathic vs. Osteopathic Physicians As the medical field continues to evolve and diversify, it is imperative to understand the impact of physician education on patient outcomes and healthcare costs. This comprehensive observational study offers an insightful comparison between allopathic and osteopathic physicians in the context of hospitalized Medicare patients, revealing striking similarities in both the quality and cost of care provided.
Family Medicine/General Practice June 6th 2023
MashupMD
Enhancing Cardiovascular Disease Risk Prediction: Comparing Coronary Artery Calcium and Polygenic Risk Scores A Northwestern University study revealed that both coronary artery calcium and polygenic risk scores significantly influence 10-year risk prediction for coronary heart disease. However, coronary artery calcium score demonstrated superior predictive power, reinforcing the integration of these novel tools in risk prediction models. “What this study says is that in white participants enrolled in 2 observational studies, identifying coronary calcium predicted future cardiac events better than our currently available polygenic risk scores.” Dr. Karol E. Watson, PhD, professor of medicine and cardiology at the David Geffen School of Medicine at the University of California Los Angeles
Cardiology June 6th 2023